EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY 4.0

A Novel Infant Formula with Medium- and Long-Chain Triacylglycerols and sn-2 Palmitate Supports Adequate Growth and Lipid Absorption in Healthy Term Infants

Xiaoyan Chen, Mengtao Yang iD, Wei Wei iD, Siyu Huang, Yingzhen Qiu, Zhen Li, Qiuye Lan, Bixia Huang, Tong Wu, Qianqian Bi, Xingguo Wang, Huilian Zhu

Nutrients · 2025

DOI: 10.3390/nu17091401 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Nutrients, 2025. Verfasst von Xiaoyan Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Food, Nutrition and Health, School of Public Health, Sun Yat-sen University, Guangzhou 510080, China. Hauptthemen laut MEDLINE: Child Development, Infant Formula, Infant Nutritional Physiological Phenomena, Lipid Metabolism. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Medium- and long-chain triacylglycerols (MLCTs) and sn-2 palmitate constitute approximately 70~80% of total breast milk fat. The structured lipid MLCTs and sn-2 palmitate, mimicking human milk, have demonstrated improvement in lipid absorption and energy metabolism in vitro and in animal experiments. However, clinical trials on infant formula supplied with MLCTs and sn-2 palmitate have yet to be conducted.

Objectives

This study was designed to evaluate the effects on growth and lipid absorption of a novel formula with structured lipid MLCTs and sn-2 palmitate on healthy infants born at term.

Methods

Infants were enrolled at 30 d postpartum and assigned to three groups based on their feeding conditions: (1) a novel formula with MLCTs and sn-2 palmitate (Novel-F group, n = 65); (2) a control formula with vegetable oils and no structured lipids (Contr-F group, n = 46); or (3) breastfeeding (BF group, n = 66). Growth measurements (including weight, length, and head circumference), stool characteristics, and fecal lipid composition (both soap and non-soap fatty acids) were analyzed at both baseline (30 d postpartum) and endline visits (90 d postpartum).

Results

The Novel-F group had significantly higher weight gains (2195 ± 595 g) during the intervention compared to the Contr-F group (1897 ± 483 g) but similar weight gains to the BF group (2081 ± 614 g), with the changes in Zw/a following a similar pattern. Zl/a increased in the Novel-F group (0.04, (95% CI: −0.21 to 0.28)) and decreased in both the Contr-F (−0.23 (95% CI: −0.52 to 0.06)) and BF groups (−0.20 (95% CI: −0.44 to 0.05)). The stools of infants in the Novel-F group had similar undigested triacylglycerols and total fatty acids compared to breastfed infants but had significantly lower levels than infants fed with the control formula at both baseline and endline visits.

Conclusions

The novel infant formula with MLCTs and sn-2 palmitate is safe and well tolerated, and supports adequate weight gain and improves lipid absorption.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Child DevelopmentInfant FormulaInfant Nutritional Physiological PhenomenaLipid MetabolismPalmitatesTriglyceridesFemaleHumansInfantInfant, NewbornMaleBreast FeedingFecesIntestinal AbsorptionMilk, HumanWeight Gain

Stichwörter der Autor:innen

adequate growthhuman milkinfant formulalipid absorptionmedium- and long-chain triacylglycerolsn-2 palmitatestructured lipid

Substanzen

PalmitatesTriglycerides

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Food, Nutrition and Health, School of Public Health, Sun Yat-sen University, Guangzhou 510080, China.
  • State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi 214122, China.

ORCID-Profile: Mengtao Yang, Wei Wei

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Chen, X., Yang, M., Wei, W., Huang, S., Qiu, Y., Li, Z., Lan, Q., Huang, B., Wu, T., Bi, Q., Wang, X., & Zhu, H. (2025). A Novel Infant Formula with Medium- and Long-Chain Triacylglycerols and sn-2 Palmitate Supports Adequate Growth and Lipid Absorption in Healthy Term Infants. Nutrients. https://doi.org/10.3390/nu17091401

Vancouver

Chen X, Yang M, Wei W, Huang S, Qiu Y, Li Z, et al. A Novel Infant Formula with Medium- and Long-Chain Triacylglycerols and sn-2 Palmitate Supports Adequate Growth and Lipid Absorption in Healthy Term Infants. Nutrients. 2025. doi:10.3390/nu17091401

BibTeX
@article{Chen2025,
  author = {Chen, Xiaoyan and Yang, Mengtao and Wei, Wei and Huang, Siyu and Qiu, Yingzhen and Li, Zhen and Lan, Qiuye and Huang, Bixia and Wu, Tong and Bi, Qianqian and Wang, Xingguo and Zhu, Huilian},
  title = {A Novel Infant Formula with Medium- and Long-Chain Triacylglycerols and sn-2 Palmitate Supports Adequate Growth and Lipid Absorption in Healthy Term Infants},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17091401}
}
Kostenlos starten →